Skip to main content

Table 1 Susceptibilities to additional antimicrobials stratified by carbapenem susceptibility

From: Predictors of hospital mortality among septic ICU patients with Acinetobacter spp.bacteremia: a cohort study

Drug

Carbapenem-S

Carbapenem-NS

S

R

I

NR

S

R

I

NR

Cefepime

31

17

2

0

1

74

1

0

Ciprofloxacin

27

17

5

1

0

74

1

1

Gentamycin

37

10

2

1

31

34

10

1

Piperacillin-Tazobactam

22

16

9

3

1

71

3

1

Tobramycin

19

1

0

30

28

20

8

20

Trimethoprim-Sulfamethoxazole

34

13

2

1

8

67

0

1

Amikacin

3

1

0

46

27

20

5

24

Ampicillin-Sulbactam

0

0

2

48

4

16

19

37

Aztreonam

1

0

0

46

41

0

0

35

Colistin

4

0

0

46

53

0

0

23

Minocycline

2

2

0

46

20

24

8

24

Tygecycline

0

2

0

48

5

7

17

47

Doxycycline

0

2

0

48

19

19

2

36

  1. S = susceptible, NS = non-susceptible, R = resistant, I = intermediate, NR = not reported.